Barclays »

Passage Bio shares owned by Barclays

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7k 212 8.03

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Passage Bio

Lynx1 Capital Management
Vestal Point Capital
Erste Asset Management GmbH
Vanguard Group
Renaissance Technologies
Tang Capital Management
OrbiMed Advisors
BlackRock
Geode Capital Management
Acadian Asset Management
Squarepoint Ops
Bridgeway Capital Management
Citadel Advisors
Fiduciary Trust Company
Tower Research Capital

View all funds holding Passage Bio